Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 500 results for "fortis cancer institute"

Deepika Padukone launches NDTV Fortis Health4U
Page3 Bollywood

Fortis Healthcare launches 'Fortis Cancer Institute' at Mohali

The institute is by far one of the most comprehensive cancer treatment centres in Punjab. National Liver Foundation announces "Get Teated" on World Hepatitis Day Ranbaxy acquisition is very important to me: Shanghvi Monsoon Diseases: Prevention is better than ... India Infoline, 1 month ago

Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. On Autophagy To Find New Cancer Treatments

TOKYO , Aug. 8, 2014 /PRNewswire/ --Cancer Research UK and its commercial arm, Cancer Research Technology ("CRT"), are to join forces with Astellas Pharma Inc. ( Tokyo , President & CEO: Yoshihiko Hatanaka , "Astellas") to find new drug targets in ...
 BioSpace1 month ago Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer  RCL Advisors1 week ago BioTime : Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer  4 Traders1 week ago CANCER RESEARCH UK AND CANCER RESEARCH TECHNOLOGY JOIN FORCES WITH ASTELLAS ON AUTOPHAGY TO FIND NEW CANCER TREATMENTS  Scottrade1 month ago

Run for cancer awareness on August 3

People need not fear cancer, only delay in diagnosis, said V. Shanta, chairperson of Cancer Institute, Adyar. To take this message forward, the Institute, as part of its diamond jubilee celebrations, is organising an awareness run Race Against ...
 The Hindu1 month ago

Specialty care to be a focus for Fortis

Fortis Healthcare plans to focus on specialty centres, such as mother and child, oncology (cancer) and cardiac care for growth, said Aditya Vij, Chief Executive Officer (CEO). The company, which has a target of adding 500-600 beds each year, is ...
 Hindu Business Line2 months ago Fortis Healthcare plans to focus on specialty centres: reports  India Infoline1 month ago

Cancer Genetics' Proprietary Genomic Diagnostic Tests Added to National Institutes of Health's Genetic Testing Registry

Online database allows clinicians and patients to search for genetic and genomic tests by disease state Increases access to information about and awareness of Cancer Genetics' proprietary diagnostic tests RUTHERFORD, N.J., Aug. 27, 2014 (GLOBE ...
 Street Sweeper3 weeks ago Cancer Genetics nabs Gentris Corporation  Drug Discovery News1 month ago Cancer Genetics Announces Acquisition of Gentris Corporation, a Leading Global Pharmacogenomics Company, and Increases Contract Backlog to Over $18 Million  Wall Street Select1 month ago Cancer Genetics, Inc. Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million  BioSpace1 month ago

National Cancer Institute at the Centre of Ambitious €3m National Cancer Plan

At a press conference at the Ministère de la Santé (Ministry of Health) on Tuesday 2 September, the Plan National Cancer (National Cancer Plan) was officially presented to the media. Newly-elected under the Bettel administration, Health ...
 Chornicle.lu2 weeks ago

New drug target can break down cancer's barrier against treatment

PUBLIC RELEASE DATE: 27-Jul-2014 CANCER RESEARCH UK scientists at Barts Cancer Institute have found that targeting a molecule in blood vessels can make cancer therapy significantly more effective, according to research published in Nature today ...
 EurekAlert!1 month ago

Practice Changing (Again): Stereotactic RT for Lung Cancer

SAN FRANCISCO ― There was no significant increase in late toxicity when stereotactic body radiation therapy (SBRT) was used in the treatment of early-stage ― but inoperable ― nonsmall-cell lung cancers (NSCLCs), according to new 5-year ...
 General Medicine eJournal1 day ago

Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study [Urologic Oncology]

⇑, Christopher J. Sweeney , Paul G. Corn , Dana E. Rathkopf , David C. Smith , Maha Hussain , Daniel J. George , Celestia S. Higano , Andrea L. Harzstark , A. Oliver Sartor , Nicholas J. Vogelzang , Michael S. Gordon , ...
 Journal of Clinical Oncology3 days ago
Review Seeker

Aethlon receives IRB approval to begin human clinical studies of Hemopurifier therapy

Aethlon Medical, the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, has recently received independent internal review board (IRB) approval to initiate human clinical ...
 PharmaBiz2 weeks ago Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Announces Receipt of IRB Approval to Initiate Hemopurifier Clinical Studies  InvestorIdeas.com2 weeks ago Aethlon Medical Obtains IRB Approval To Initiate Hemopurifier Clinical Studies  RTTNews.com2 weeks ago Aethlon Medical Announces Receipt of IRB Approval to Initiate Hemopurifier® Clinical Studies  Minyanville2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less